Cyprotex

📍 Macclesfield, United Kingdom🗓 Founded 1999👥 206 employees💰 Last funded 2004
Research Services🌐 cyprotex.com
Website LinkedIn
Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and USA, was acquired by Evotec (www.evotec.com) in 2016. The Evotec Group offer expert support from early discovery through to clinical development. * High-throughput ADME screening * Customised ADME assays * In silico ADME predictive modeling * In vitro toxicology
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
1999
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Cyprotex?
Cyprotex has 1 investors on record on gritt.io, 1 mid-stage.
When did Cyprotex last raise funding?
The most recent investment in Cyprotex recorded on gritt.io was in 2004.
When was Cyprotex founded?
Cyprotex was founded in 1999.
What industry is Cyprotex in?
Cyprotex operates in Research Services. Find similar Research Services investors on gritt.io.
Where is Cyprotex based?
Cyprotex is headquartered in Macclesfield, United Kingdom.